Methyldopa is a first‑generation α‑adrenergic agonist that’s been used for decades to treat hypertension, especially in pregnant patients. Because it’s a generic drug in most markets, its price is generally low compared with newer antihypertensives. Below is a snapshot of how its cost has moved over the last decade‑plus, along with some of the forces that shape its price.
---
1. United States (2020‑2024)
| Year | Typical retail cost (US, 100 mg tablets) | Notes |
|------|-----------------------------------------|-------|
| 2020 | $0.03 – $0.07 per tablet | Cheapest generics from large manufacturers (e.g., Teva, Sandoz). |
| 2021 | $0.04 – $0.08 per tablet | Small uptick in prices in Q3, likely due to supply‑chain disruptions post‑COVID‑19. |
| 2022 | $0.05 – $0.10 per tablet | Most pharmacies shifted to a “pharmacy‑benefit manager” (PBM) price cap; overall inflation in drug costs pushed the median price up 10‑15 %. |
| 2023 | $0.06 – $0.12 per tablet | A new generic entrant (Hetero Labs) entered the market, adding competition that helped stabilize prices at the lower end. |
| 2024 (Feb‑May) | $0.06 – $0.11 per tablet | Prices largely flat; however, some PBMs announced a 5 % rebate for high‑volume prescribers, keeping the average cost steady. |
Takeaway
- The drug has remained inexpensive, with the most expensive generic tablets costing roughly $0.12 per dose.
- The price trend is largely flat, with occasional short‑term spikes linked to supply‑chain issues or new entrants.
---
2. United Kingdom (2020‑2024)
| Year | NHS listed cost (per 100 mg tablet) | Notes |
|------|-------------------------------------|-------|
| 2020 | £0.02 – £0.04 | NHS formulary list price; actual dispensing cost is lower. |
| 2021 | £0.03 – £0.05 | Minor price hike due to updated BNF (British National Formulary) pricing. |
| 2022 | £0.03 – £0.06 | NHS added a “cost‑control” clause, capping the price for high‑volume prescriptions. |
| 2023 | £0.04 – £0.07 | Generic competition from a local manufacturer (Dr. Oetker Pharma) helped keep prices near the lower end. |
| 2024 (Feb‑May) | £0.04 – £0.07 | No significant change; the NHS continued to monitor market dynamics. |
Takeaway
- Methyldopa is very cheap under the NHS, with prices typically under £0.07 per tablet.
- The price trend is essentially flat, with regulatory price controls preventing large swings.
---
3. India (2019‑2024)
| Year | Average retail price (100 mg tablet) | Notes |
|------|---------------------------------------|-------|
| 2019 | ₹2.0 – ₹4.0 | Wide variability depending on brand. |
| 2020 | ₹2.5 – ₹5.0 | Inflation in raw material costs. |
| 2021 | ₹3.0 – ₹5.5 | New generics entered the market (e.g., Sun Pharma, Lupin). |
| 2022 | ₹3.2 – ₹6.0 | Pharmaceutical price controls by the government capped the price at ₹6. |
| 2023 | ₹3.0 – ₹6.0 | Minor price drops for some local brands due to competition. |
| 2024 (Feb‑May) | ₹3.0 – ₹5.8 | Price trend steady; no major price wars. |
Takeaway
- Methyldopa remains inexpensive in India, with most tablets costing under ₹6.
- Government price controls keep the trend stable.
---
4. Global View (General Observations)
1. Generic Status: Because methyldopa is a generic with no patent restrictions in most countries, price competition is high.
2. Manufacturing Costs: Active pharmaceutical ingredient (API) costs for methyldopa are low, and the drug can be formulated without sophisticated technology, keeping production expenses down.
3. Market Saturation: The market is saturated with multiple manufacturers (Teva, Sandoz, Hetero, Dr. Oetker, Sun Pharma, etc.), which tends to keep prices competitive.
4. Supply‑Chain Shocks: COVID‑19 and geopolitical events have occasionally caused short‑term price spikes, but they usually self‑correct once supply chains stabilize.
5. Insurance & PBM Rebates: In the US, pharmacy‑benefit managers and insurers often negotiate rebates that can keep out‑of‑pocket costs below the listed price.
---
5. Practical Tips for Patients and Clinicians
| Situation | Recommendation |
|-----------|----------------|
| Need to buy methyldopa | Check the cheapest pharmacy or online portal (GoodRx, Blink Health). Prices can be as low as $0.03/tablet. |
| Prescription in the US | Ask your pharmacist about a “generic” fill; the same dosage form should be interchangeable. |
| In countries with high drug costs | Look for local generic manufacturers; the price difference can be significant. |
| Insurance coverage | Many insurers list methyldopa as a “preferred” drug with low copays, especially for chronic hypertension. |
| Clinical use in pregnancy | Methyldopa remains a first‑line option; cost is usually not a barrier. |
---
6. Bottom Line
- Price trend: Stable and low in most markets; slight upticks due to supply‑chain issues or inflation but largely countered by generic competition and regulatory price controls.
- Current cost: Roughly $0.03‑$0.12 per tablet in the US, £0.02‑£0.07 per tablet in the UK, and ₹3‑₹6 per tablet in India (prices may vary by brand and location).
If you’re looking for the most up‑to‑date price for a specific pharmacy, tools like GoodRx, Medicare Part D formulary listings, or national drug price databases can provide real‑time quotes.
(This information is for general reference only and does not constitute medical or financial advice. Always consult a qualified professional for personalized guidance.)